CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

bbv154

Vaccineexperimental

Clinical trial activity

4 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
0

Earliest trial started Mar 1, 2021 (NCT04751682)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2022

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • SARS-CoV-2Immunity, active

    SARS-CoV-2 immunity, active

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05522335Phase 3Apr 16, 2022Bharat Biotech International Limited
NCT05567471Phase 3Feb 26, 2022All India Institute of Medical Sciences, Bharat Biotech International Limited, ESIC Medical College and Hospital Faridabad, Jeevan Rekha Hospital, Belguam
NCT05639998Phase 2Sep 1, 2021Bharat Biotech International Limited
NCT04751682Phase 1Mar 1, 2021Bharat Biotech International Limited
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Bharat Biotech International LimitedFor profit4432021
All India Institute of Medical SciencesAcademic/Hospital1012022
ESIC Medical College and Hospital FaridabadAcademic/Hospital1012022
Jeevan Rekha Hospital, BelguamAcademic/Hospital1012022
4 organizations
Page 1 / 1